Whalegun
Home

Amneal Pharmaceuticals AMRX spent $340K on lobbying in Q4 2025 · Health Issues

Trade details

Type
Lobbying report
Amount
$340,000
Quarter
Q4 2025
Stock
Amneal Pharmaceuticals AMRX
Client
Amneal Pharmaceuticals
Reported
26/01/20

Up 9.7% from last quarter

What else happened in Amneal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Amneal Pharmaceuticals's other lobbying reports